Fierce Pharma
NOVEMBER 22, 2024
As other Big Pharmas face local headwinds, Pfizer doubles down on China commitment with Zai Lab antimicrobial marketing pact fkansteiner Fri, 11/22/2024 - 09:04
MedCity News
NOVEMBER 22, 2024
During a recent panel discussion, three healthcare experts discussed reasons why value-based care is struggling to reach scale. The post Value-Based Care Is a Four Layer Cake — Why Do We Only Focus on The Icing? appeared first on MedCity News.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
NOVEMBER 22, 2024
While Johnson & Johnson hopes to soon resolve more than 60,000 talc lawsuits with an $8 billion bankruptcy settlement in the United States, its baby power problems are only just beginning in th | While Johnson & Johnson hopes to soon resolve more than 60,000 talc lawsuits with an $8 billion bankruptcy settlement in the United States, its baby power problems are only just beginning in the U.K.
MedCity News
NOVEMBER 22, 2024
A patient death in a clinical trial usually prompts the FDA to impose a clinical hold. But Neurogene is able to avoid a lengthy clinical trial pause largely because of its participation in an FDA pilot program intended to speed up the development of therapies for rare diseases. The post Patient Dies in Gene Therapy Trial, But FDA Permits Neurogene to Proceed With Low Dose appeared first on MedCity News.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Fierce Pharma
NOVEMBER 22, 2024
For many biopharmas, it takes years of hard work to transition from being a clinical-stage drugmaker to a commercial one. Companies rarely want to make the shift back. | The pivot comes after the FDA issued a notice that the deficiencies in the company's approval bid for type 1 diabetes med Zynquista are too great to proceed for further discussion.
MedCity News
NOVEMBER 22, 2024
By addressing each community’s unique needs with tailored, culturally responsive care and cross-sector collaboration, we can empower healthcare providers to drive lasting, equitable outcomes. The post Closing America’s Diabetes Divide: A $412 Billion Opportunity to Transform Diabetes Care appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
NOVEMBER 22, 2024
Seen Health emerged from stealth on Monday. The company builds on the Program of All-Inclusive Care for the Elderly model and focuses on Asian and Pacific Islander communities. The post Twin Brothers Launch Seen Health with $22M to Provide Culturally-Focused Care for Seniors appeared first on MedCity News.
pharmaphorum
NOVEMBER 22, 2024
The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
MedCity News
NOVEMBER 22, 2024
Wearable devices, such as a glucose meter device or a defibrillator and pacemaker, can provide valuable and real-time information to a healthcare provider so that decisions can be made to protect the patient. The post Wearable Health Tech: Innovations and Impacts on Chronic Disease Management appeared first on MedCity News.
PharmaVoice
NOVEMBER 22, 2024
Despite a plan to shutter 1,200 stores, the company’s chief clinical trials officer said the pharmacy juggernaut remains committed to drug research.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
eMediWrite
NOVEMBER 22, 2024
Becoming an outstanding product manager in the pharmaceutical industry and creating a top-tier brand demands a blend of strategic insight, industry expertise, and flawless execution. Here’s a comprehensive guide to help you excel and establish a number-one product in the market. 1. Deeply Understand Your Market and Audience To create a leading product, you need to understand the therapeutic area thoroughly.
Pharmaceutical Commerce
NOVEMBER 22, 2024
In the third part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Gaurav Gupta, managing director and head of R&D at Kotter, comments on the specific technical and soft skills that are critical in order for pharma leaders and frontline employees to excel in ever-changing industry landscape, while explaining why these skills are beneficial when it comes to being proactive in handling talent shortages.
European Pharmaceutical Review
NOVEMBER 22, 2024
A new method to improve mRNA delivery has been developed by US researchers, which could enhance the safety and efficacy of mRNA vaccines and therapies. Ionisable lipid molecules are at the centre of lipid nanoparticles (LNPs) and can switch between charged and neutral states, ultimately releasing the mRNA payload when positively charged in the target cell.
Contrarian Sales Techniques
NOVEMBER 22, 2024
The medical device sales field in Malaysia is one of the most dynamic and rewarding sectors within healthcare. It combines technical knowledge, relationship-building, and sales expertise to bring life-saving equipment to the people who need it most. But if you’re considering a career in this space, there are many lesser-known aspects that can shape your journey.
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
Clarify Health
NOVEMBER 22, 2024
More than a third of patients are referred to a specialist every year, at a cost of more than $75 billion annually. Specialty care is often necessary, but effective referral management can help payers control costs and ensure it is warranted, efficient, and high-quality. The key to all this: insights powered by data. Greater visibility into patterns and trends related to patient outcomes, provider performance, and costs can help health plans see where changes need to be made to optimize c
PharmExec
NOVEMBER 22, 2024
Johnson & Johnson has submitted a supplemental Biologics License Application to the FDA for a subcutaneous induction regimen of Tremfya for adults with moderately to severely active ulcerative colitis based on positive Phase III ASTRO trial results.
Contrarian Sales Techniques
NOVEMBER 22, 2024
If you’re thinking about a career in medical sales for a local generic pharmaceutical company in Malaysia, you might already know it’s a fast-paced and competitive field. But what you might not know is just how unique this sector is compared to multinational companies or other industries. Here are 10 little-known facts about working as a medical sales rep in a local generic pharma company—and what you can expect from this dynamic and rewarding role. 1.
Pharmaceutical Technology
NOVEMBER 22, 2024
Several pharmaceutical companies are advancing dry powder inhalers (DPIs) for respiratory conditions in an effort to cut down on greenhouse emissions and create a solution that is more eco-friendly than traditional pressurised metered-dose inhalers (pMDIs).
Tribeca Knowledge
NOVEMBER 22, 2024
A pproval rates for innovative medicines in the EU have bounced back this year after a rather subdued performance in 2023. The US, on the other hand, is struggling to keep pace with last year’s registration bonanza. Let’s take a look at what the pace and emphasis of 2024’s new drug approvals i n these key markets tell us about the industry’s current state of health.
PharmaTech
NOVEMBER 22, 2024
The company has expanded its early and late phase analytical capabilities by including GMP cell-based potency assays at its sites in Cambridge, UK, and San Diego, Calif.
Pharmaceutical Technology
NOVEMBER 22, 2024
Novartis has announced the acquisition of Kate Therapeutics to enhance its portfolio of gene therapies for inherited neuromuscular diseases.
pharmaphorum
NOVEMBER 22, 2024
AstraZeneca is facing some pushback as it tries to upgrade anticoagulant antidote drug Andexaa to full approval in the US.
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
Pharmaceutical Technology
NOVEMBER 22, 2024
The biotech uses its AI platform to discover the therapeutic potential of plant-based molecules, advancing ten candidates with the funds.
PharmExec
NOVEMBER 22, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmaceutical Technology
NOVEMBER 22, 2024
Health Canada has issued a Notice of Compliance (NOC) for Johnson & Johnson’s (J&J) CARVYKTI for multiple myeloma treatment.
PharmExec
NOVEMBER 22, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmaceutical Technology
NOVEMBER 22, 2024
Johnson & Johnson Innovation Medicine has submitted a request to the FDA to approve Tremfya as a treatment for ulcerative colitis.
PharmExec
NOVEMBER 22, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmaceutical Technology
NOVEMBER 22, 2024
The UK’s proposed regulations would provide the legal framework for POC manufacturing of cell therapies, including quality assurance.
PharmaTech
NOVEMBER 22, 2024
Sanofi will use this investment to increase its antibody bioproduction at its site in Lyon Gerland, France.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Expert insights. Personalized for you.
184 
Let's personalize your content